Consistently, real‐time quantitative PCR and western blotting assays in five breast cancer cell lines indicated that a sharp decrease in KDM6B mRNA and protein levels occurred compared with mammary MCF10A cells (Fig. 1C,D). This evidence concerns the gene KDM6B and breast carcinoma.